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Abstract
Toxoplasma gondii is an intracellular parasite that invades nucleated cells, causing toxoplasmosis in humans and animals
worldwide. The extremely wide range of hosts susceptible to T. gondii is thought to be the result of interactions between T.
gondii ligands and receptors on its target cells. In this study, a host cell-binding protein from T. gondii was characterized, and
one of its receptors was identified. P104 (GenBank Access. No. CAJ20677) is 991 amino acids in length, containing a putative
26 amino acid signal peptide and 10 PAN/apple domains, and shows low homology to other identified PAN/apple domain-
containing molecules. A 104-kDa host cell-binding protein was detected in the T. gondii lysate. Immunofluorescence assays
detected P104 at the apical end of extracellular T. gondii. An Fc-fusion protein of the P104 N-terminus, which contains two
PAN/apple domains, showed strong affinity for the mammalian and insect cells evaluated. This binding was not related to
protein-protein or protein-lipid interactions, but to a protein-glycosaminoglycan (GAG) interaction. Chondroitin sulfate (CS),
a kind of GAG, was shown to be involved in adhesion of the Fc-P104 N-terminus fusion protein to host cells. These results
suggest that P104, expressed at the apical end of the extracellular parasite, may function as a ligand in the attachment of T.
gondii to CS or other receptors on the host cell, facilitating invasion by the parasite.
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Introduction
Toxoplasma gondii is a common intracellular parasite that causes
serious symptoms in immunocompromised individuals and
pregnant women [1]. Following infection, the parasite can persist
for the life of the organism; thus, approximately 50% of the
world’s population is currently carrying T. gondii. Extensive
research into drug therapies for the treatment of toxoplasmosis
has been carried out; however, most of the drugs in use are toxic
[2], and T. gondii can readily develop drug resistance [3]. In fact,
they are currently being administered to not only infected ordinary
adults but also infected pregnant women and newborns who are
more weak and susceptible to the toxicity [4].
The most promising measure for the protection of humans and
animals against T. gondii infection is vaccination. Vaccination with
SAG1, affinity-purified from the T. gondii RH strain, produced high
survival rates and significantly decreased brain cyst loads in mice [5–
8]. Also, the use of a combination of antigens delivered as plasmids
coding for regions of micronemal proteins, including MIC2, MIC3,
MIC4, M2AP, and AMA1, resulted in a significant reduction (84%)
in the number of cysts [9]. Interestingly, almost all protective
molecules seem to be involved in the parasite-host interaction [10].
Thus, the exploration of this type of molecule from T. gondii appears
to be extremely important for vaccine development.
Toxoplasma gondii has the remarkable ability to invade a broad
range of cell types. This parasite is believed to attach to host cells
via ubiquitously expressed surface molecules of the host, or each
host cell type may carry a unique receptor that is bound by a
particular parasite molecule [11]. Fourteen PAN/apple domain
proteins have been detected in T. gondii [12], although only two
(TgAMA1 and TgMIC4) have been described [13,14]. TgAMA1
was shown to form a complex, called a moving junction (MJ), with
the neck of the rhoptries (for RON2/RON4/RON5 proteins)
during the invasion process [15]. The depletion of TgAMA1
prevented MJ formation, and the parasite was consequently
unable to invade host cells [16]. TgMIC4 has been shown to bind
with and serve as a bridge between the parasite and host cell [13].
Since PAN/apple domain proteins from most species bind other
proteins or carbohydrates [17], members of this family from T.
gondii may mediate inter-specific interactions, thereby providing a
link between host and parasite. To explore the function or
characters of other members of the family, we selected a sequence
containing several PAN/Apple domains from the GenBank,
characterized the protein and identified one of its receptors on
host cell surface.
Glycosaminoglycans (GAGs), or mucopolysaccharides, are long
unbranched polysaccharides consisting of a repeating disaccharide
unit [18]. GAGs include chondroitin sulfate (CS), dermatan
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hyaluronan, among which CS is the most prevalent GAG
component [19]. Cell surface GAGs are utilized as a receptor by
a variety of pathogens, including Chlamydia [20], Trypanosoma [21],
Plasmodium [22], and Toxoplasma [11,18]. A surface antigen from T.
gondii, SAG3, was shown to interact with HS on the surface of
Chinese hamster ovary (CHO)-K1 cells [23]; however, other
molecules that bind GAGs have not yet been identified. In the
present study, CS was shown to bind a PAN/apple domain-
containing protein from T. gondii, suggesting that various GAGs
may function as receptors in parasite-host cell attachment.
Materials and Methods
Biochemical reagents and antibodies
CSA and CSC were purchased from Sigma-Aldrich. Rabbit
anti-M2AP (microneme protein 2-associated protein) polyclonal
antibodies were kindly provided by Dr. V. Carruthers (John
Hopkins University, Baltimore, MD); rabbit anti-ROP1 polyclonal
antibodies were a gift from Dr. J. Dubremetz (University of
Montpellier, Montpellier, France); rabbit anti-GRA6 polyclonal
antibodies were kindly sent to us by Dr. L.D. Sibley (Washington
University School of Medicine, MO, USA)
Parasites and cell culture
Tachyzoites of T. gondii RH strain [24] were inoculated in a
monolayer of Vero cells [24] cultured in Dulbecco’s modified
essential medium (DMEM; Nissui, Tokyo, Japan) supplemented
with 7.5% fetal bovine serum (FBS). 293T cells [24,25] were
cultured in DMEM with 10% FBS. CHO-K1 cells and two
mutant strains of CHO-K1, pgsA-745 and pgsD-677 cells, were
purchased from the American Type Culture Collection (ATCC)
and cultured in F-12 (Gibco BRL, Grand Island, NY) medium
containing 10% FBS. P3U1 [26], K562 (Riken BRC Cell Bank,
Ibaraki, Japan), and Jurkat cells [27] were maintained in
RPMI1640 medium (Sigma-Aldrich) with 10% FBS. Insect cells
(Spodoptera frugiperda Sf9 [24,25] and Trichoplusia ni Tn5 [25]) were
cultured in Sf-900II SFM (Invitrogen, Carlsbad, CA) and Ex-cell
405 (SAFC Biosciences Inc., Lenexa, KS), respectively.
Recombinant protein synthesis
Using the sequence obtained from GenBank (CAJ20677),
primers were designed for plasmid construction in pBSV-Fc-
8His [25]. The N-terminus of the protein contains four repeats of
similar amino acid residues; the forward primer, P104-1-Fc-F
(59-GGACTAGTAGAGGAAAGCCTGAATACAGTCAACG-39;
SpeI site underlined), and reverse primer, P104-1-Fc-R (59-
TGAATTCCACGATTCGGACTCCTCCTCAGT-39; EcoRI
site underlined), were designed to flank the ends of this repeat
(Fig. 1A). The resulting PCR products contained one (P104-1-S) or
two repeats (P104-1-B). The forward primer for the C-terminus
was P104-2-Fc-F (59-CAGGATCCGAGGCGCTGCCGGGTG-
39; BamHI site underlined), while the reverse primer was P104-2-
Fc-R (59-TCACCCGGGGCAGAAATCCCTGGGACCGAC-
Figure 1. Analysis of the P104 protein sequence. A. The signal peptide is indicated by black rectangle. A1, A3, A5, and A7 are indicated by a
dark gray rectangle. A2, A4, A6, and A8 are indicated by a light gray rectangle. A9 and A10 are shown in light black and shiny black rectangles. The
arrows at the N- and C-termini indicate the designated primers; the corresponding PCR products are indicated by black bands. B. The putative apple-
like structure of a PAN/apple domain. C1–C6 (shown in bold) indicate the six cysteine residues that form three disulfide bridges.
doi:10.1371/journal.pone.0030169.g001
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of P104, constructed in pGEX-6P-2 and expressed in E. coli, was
P104-1-GST-F (59-GGAATTCCCAGAGGAAAGCCTGAATA-
CAGTCAAC-39;E coRI site underlined); the reverse primer was
P104-1-GST-R (59-GCGGCCGCCGATTCGGACTCCTCCT-
CAGT-39; NotI site underlined). Construction of the plasmids and
expression of the recombinant proteins in Tn5 insect cells was
done as described previously [25] with the following modifications.
Briefly, total RNA was prepared from T. gondii RH strain following
propagation in Vero cells using Trizol reagent (Invitrogen). Next,
RT-PCR was done using the SuperScript III one-step RT-PCR
system with platinum Taq DNA polymerase (Invitrogen). The
amplified products were cloned into pBSV-Fc-8His and their
sequences confirmed. Subsequently, the positive clones were co-
transfected with BaculoGold DNA (BD Biosciences, San Jose, CA)
into Sf9 insect cells, and used to infect Tn5 cells. The fusion
proteins, designated as rP104-1-S/Fc, rP104-1-B/Fc, and rP104-
2/Fc, were purified from the lysate of the culture medium of the
infected Tn5 cells. Moreover, the expression of Fc-recombinant
proteins was confirmed by Western blotting using anti-mouse Fc
antibody. Expression of the GST-recombinant protein (rP104-1/
GST) in pGEX-6P-2 was carried out according to the manufac-
turer’s protocol.
Anti-rP104-1/GST serum preparation, Western blotting,
and immunofluorescence assay (IFA)
Mice were immunized three times with rP104-1/GST to
produce anti-rP104-1/GST antibodies. This work was approved
by the Research Ethics Review Committee of Graduate School of
Agricultural and Life Sciences, the University of Tokyo (Approval
no. P08-183). Anti-sera and normal sera were prepared and
collected as described previously [28]. For Western blotting, strain
RH was propagated and lysed by passing the cells though a #27
syringe and filtered using a 5-mm filter. The purified tachyzoites
were lysed in 16 SDS-PAGE buffer, boiled for 5 min, and
subjected to 10% SDS-PAGE and Western blotting using Immun-
Blot PVDF membranes (Bio-Rad). The primary antibody was
diluted 1:100 in phosphate-buffered saline [PBS] with 0.1%
Tween 20 and 1% BSA and incubated with the membrane for
1 h. Detection was performed as described previously [28]. For
IFA, purified tachyzoites were fixed on a 14-well slide and
permeabilized with 0.1% Triton X-100. The slide was then
reacted with anti-rP104-1-S/GST antibodies followed by goat
anti-mouse IgG-Alexa Fluor 488 (Invitrogen). Rabbit anti-M2AP,
anti-ROP1 and anti-GRA6 antibodies were employed for co-
localization assays with P104 in T. gondii. Intracellular T. gondii was
prepared by the infection of Vero cells cultured in an eight-well
chamber slide for 48 h; the slide was fixed and stained as described
above. Initial attempts to localize P104 inintracellular T.gondii relied
on antibodies to rP104-1-S/GST were unsuccessful. As an
alternative strategy, we introduced a FLAG tag to the C-terminus
of P104 and transfected into RH parasites using pMini.36Flag.ht.
vector under the control of GRA1 promoter [29]. Firstly, genome
DNA was extracted from purified T. gondii and subjected to a PCR
reaction using the following primers, which generated restriction
sites EcoT22I and BglII: 59-AGAAATCAAGCAAGATGTG-
GAAGTACGGATTTTTTCTGACAG-39 (sense) and 59CTG-
GTACCGATATCAGAGAAGGGCAGAAATCCCTGGGAC-39
(antisense). The purified PCR product was blunted with DNA
blunting kit (TaKaRa, Japan) and then inserted into digested and
blunted pMini.36Flag.ht. vector using In-Fusion HD EcoDry
cloning kit (Clontech, Japan). The 15 bp overlap was underlined
in the primers. Fifty microgram plasmid of identified positive clone
was transiently transfected into 1610
6 purified T. gondii according to
the description elsewhere [30]. And the transfected parasites were
inoculated into Vero cells cultured in 8-well slide. After 36 h of
infection, the parasites were double stained with mouse anti-FLAG
and rabbit anti-M2AP, anti-ROP1 or anti-GRA6 antibodies,
respectively.
Flow cytometry
Several types of erythrocytes (1610
5 cells) were incubated with
1.5 pmol of rP104-1-S/Fc, rP104-1-B/Fc, or rP104-2/Fc in
fluorescence activated cell sorting (FACS) buffer (PBS with 2%
FCS and 0.1% NaN3) for 1 h at 4uC. Binding of the recombinant
proteins was measured as described previously [25]. For protease
treatment, Vero, K562, and P3U1 cells were treated with 0.1 mg/
ml trypsin or chymotrypsin for 2 h at room temperature. Next,
1 mg/ml protease inhibitor was added to stop the reaction. After
washing with PBS three times, the cells were subjected to the same
incubation with 1.5 pmol of rP104-1-S/Fc followed by FACS
analysis, as described above. Flow cytometric analysis was done
using WinMDI version 2.9 software.
Lipid binding assay
To investigate the lipid binding activity of rP104-1-S/Fc, a
protein-lipid overlay assay was carried out using Membrane Lipid
Strips (Echelon Biosciences, Salt Lake City, UT) according to the
manufacturer’s protocol. The strip is a hydrophobic membrane
pre-spotted with 15 different major biologically active lipids found
in cell membranes (100 pmol per spot). It was blocked with 1%
gelatin protein (MoBiTech, Goettingen, Germany) and 1% Tween
20 (Wako, Tokyo, Japan) in PBS (PBS-T) at room temperature for
1 h, then incubated with 5 nM rP104-1-S/Fc at room tempera-
ture for 1 h with gentle shaking. Fc protein expressed from pBSV-
Fc-8His was used as a negative control. After three washes, anti-
mouse-HRP conjugate (1:5,000) in PBS with 1% gelatin protein
was added and the signal was detected by enhanced chemilumi-
nescence (ECL; Amersham Biosciences UK Ltd., Buckingham-
shire, UK). All reactions were performed in the dark.
Inhibition of rP104-1-S/Fc binding activity by CSA and
CSC
Different concentrations of CSA and CSC (0.1–20 mg/ml) were
prepared in PBS and incubated with 1.5 pmol of rP104-1-S/Fc for
1 h at 4uC, after which the mixture was incubated with CHO-K1
cells (1610
5 cells) for 1 h at 4uC. The binding activity was
analyzed by flow cytometry as described above. To confirm the
binding of rP104-1-S/Fc to CS on the host cells, two mutant
CHO-K1 cell lines, pgsA-745 (xylosyltransferase deficient, causing
defects in HS and CS) [31] and pgsD-677 (lacks acetylglucosami-
nyltransferase and glucuronyltransferase activity, causing depletion
of HS and increasing the concentration of CS three folds) [11],
were subjected to a binding assay with 1.5 pmol of rP104-1-S/Fc
and FACS analysis as described above. All experiments were done
in triplicate.
CSA-affinity chromatography
One milligram of CSA was coupled to cyanogen bromide
(CNBr)-activated Sepharose (Sigma-Aldrich) according to the
manufacturer’s protocol. The CSA-conjugated beads were
incubated with rP104-1-S/Fc in NP-40 lysis buffer (50 mM Tris-
HCl, 150 mM NaCl, and 1% NP-40, pH 8.0) overnight at 4uC.
The beads were then washed extensively with lysis buffer four
times and eluted in 16SDS-PAGE sample buffer. The eluate was
subjected to 10% SDS-PAGE and transferred to a PVDF
membrane (Bio-Rad). After blocking with 1% BSA in PBS-T,
P104 of T. gondii and Its Receptor
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the recombinant proteins with their expected molecular weights purified from the Tn5 (insect) cell culture medium. Right panel, purified
recombinant proteins were transferred onto a PVDF membrane and anti-mouse Fc antibody was employed to detect the Fc-recombinant protein
bands. B. CBB-stained gel showing the fusion protein rP104-1-S/GST purified from E. coli. The purified proteins are shown by arrows. The molecular
masses in kDa are shown on the left.
doi:10.1371/journal.pone.0030169.g002
Figure 3. Localization of P104 in intracellular and extracellular T. gondii. A. Western blot analysis of P104 in the T. gondii lysate. Lane 1 and 4,
Vero cell lysate; lane 2 and 5, lysate of T. gondii-infected Vero cells; lane 3 and 6, lysate of purified T. gondii. Lane 1–3, CBB-staining of Vero cell and T.
gondii lysate; lane 4–6, Western blotting of the lysates. Mouse anti-rP104-1-S/GST was used as the primary antibody. The molecular masses in kDa are
shown on the left. B. Co-localization assays of P104 with other proteins in extracellular (upper 3 panels) and intracellular (lower 3 panels) T. gondii.
Green, anti-rP104-1-S/GST antibodies; red, anti-M2AP, anti-ROP1 and anti-GRA6 antibodies; blue, nuclei (with TO-PRO-3 staining). In intracellular T.
gondii (lower 3 panels), mouse anti-FLAG antibody, instead of anti-rP104-1-S/GST, was used to stain the recombinant protein of P104 with a C-
terminal FLAG tag (green stained, arrows). Wild-type parasites that failed to be stained with anti-FLAG antibody were indicated with stars.
doi:10.1371/journal.pone.0030169.g003
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antibodies. Beads treated with coupling buffer instead of CSA
were employed as a mock trial.
In vitro inhibition of T. gondii invasion by rP104-1-S/Fc
A total of 1610
4 Vero cells were seeded in an 8-well chamber
and incubated for 1 h with 0.6 or 1.5 mM rP104-1-S/Fc or Fc
diluted in infection medium (2% FBS in DMEM). The cells were
then inoculated with 2610
5 particles of T. gondii-expressing green
fluorescent protein (GFP). Two hours after infection, the chamber
was gently washed with PBS three times before the addition of
mouse anti-SAG1 antibodies (TP3 diluted 1:1,000 in PBS; HyTest
Ltd., Turku, Finland). After 30 min of staining for SAG1 on the
extracellular parasite, the chamber was washed with PBS three
times, fixed, permeabilized, and incubated with goat anti-mouse
secondary antibodies labeled with Alexa Fluor 546 (Invitrogen).
Simultaneously, TO-PRO-3 was used to stain the nuclei of the
host cells. Finally, the slide was observed and images collected with
an LSM510 confocal microscope (Zeiss). The invasion rate was
calculated as the ratio of parasites per cell in the test group
compared to that in the control group (without added protein). To
investigate the effect of CSA on parasite invasion, various
concentrations of CSA (0–2.5 mg/ml) were added to Vero cells
prior to infection with T. gondii.
Statistical analysis
Student’s t test was used to determine the statistical significance.
Results
Sequencing of P104 and the recombinant proteins
The primary sequence of P104 is composed of 10 putative PAN/
apple domains, according to an analysis done using Prosite (www.
expasy.ch/cgi-bin/prosite). Each domain contains six cysteine
residues that form three disulfide bonds, creating an apple-like
structure (Fig. 1B). The second to fifth cysteine residues match the
consensus sequence seen in TgMIC4 (CX3CX5CX11C) [13]. These
10 PAN/apple domains are arranged as follows: A1 (residues 58–
118), A2 (122–193), A3 (229–299), A4 (303–374), A5 (410–480), A6
(484–555), A7 (591–661), A8 (665–737), A9 (844–912), and A10
(914–989). Interestingly, A1 and A2 were repeated successively four
times in the primary sequence (Fig. 1A). Here, A1 and A2 were
amplified as P104-1-S, while A1–A4 were amplified as P104-1-B;
A9 and A10 were amplified as P104-2. The P104 protein sequence
Figure 4. FACS analysis of the cellular binding activity of rP104-1-S/Fc and rP104-1-B/Fc. A. Different types of cells were incubated with
rP104-1-S/Fc before being stained with anti-Fc-FITC antibodies and subjected to FACS analysis with Cell Quest software. B. FACS analysis of cells
incubated with rP104-1-B/Fc. C. FACS analysis of cells incubated with rP104-2/Fc. In all panels, cells (solid line) and cells incubated with Fc (dotted
line) were employed as negative controls. Gray-filled histograms indicate the cells incubated with recombinant proteins.
doi:10.1371/journal.pone.0030169.g004
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containing proteins, but approximately 80% homology to m01899
(ToxoDB.org v4.1), as shown in the supplemental data of a previous
study [12]. However, m01899 has not been characterized to date.
For further analysis, rP104-1-S/Fc, rP104-1-B/Fc and rP104-2/Fc
were synthesized and confirmed by Western blot analysis (Fig. 2A).
To prepare anti-serum,rP104-1-S/GSTwasexpressedand purified
(Fig. 2B) for immunization of mice.
Identification of P104 in T. gondii
Anti-rP104-1-S/GST antibodies were prepared in mice to
enable the detection of P104 in T. gondii. As expected, a band with
a molecular size of approximately 104 kDa was found in the lysate
of purified T. gondii and Vero cells infected with T. gondii, while no
band appeared in the uninfected Vero cell lysate (Fig. 3A). The co-
localization assays of P104 with M2AP, ROP1 and GRA6
indicates that P104 was not expressed in the microneme, rhoptry
or dense granules, but at the apical end of extracellular T. gondii,
(Fig. 3B, upper panels). Because of unknown reason, we failed to
specifically localize P104 protein in intracellular parasites using
our mouse antibodies against rP104-1-S/GST. Therefore, The
ORF of P104 gene was tagged with FLAG and transfected into
RH parasites. As shown in Fig. 3B (lower panels), detection with
anti-FLAG antibody revealed that P104 protein was expressed and
secreted into parasitophorous vacuole (PV) and co-localized with
GRA6 in transfected intracellular parasite (shown by arrows),
while wild-type parasites did not stain with anti-FLAG antibody
(shown by stars).
Binding of the Fc-recombinant proteins to cells
rP104-1-S/Fc and rP104-1-B/Fc were able to attach to all of
the cell types examined, including Jurkat, K562, CHO-K1, P3U1,
and Vero cells (Fig. 4A and B); in contrast, rP104-2/Fc did not
show specific affinity for any of the tested cells (Fig. 4C). Besides
Figure 5. The attachment of rP104-1-S/Fc to host cells was not affected by protease digestion of cell surface proteins, and the
receptor was not a major lipid on the cell surface. Vero, K562, and P3U1 cells were treated with trypsin (A) or chymotrypsin (B) to remove
surface proteins, and then incubated with rP104-1-S/Fc (gray-filled histograms) or Fc (dotted line). The bound signals were detected by FACS analysis.
The solid line indicates the cell-only control. C. rP104-1-S/Fc was incubated with a membrane spotted with 15 major lipids from the cell surface (right
panel). The membrane was then immersed in HRP-conjugated anti-mouse antibodies, and reaction spots were revealed using the ECL system. Fc was
used as a negative control (central panel). The names of lipids were shown on the left panel.
doi:10.1371/journal.pone.0030169.g005
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of insect cells, Sf9 and Tn5 cells (Fig. 4A).
The role of cell surface proteins or lipids in binding to
rP104-1-S/Fc
To investigate the receptor for rP104-1-S/Fc, trypsin and
chymotrypsin were used to digest the surface proteins of Vero,
K562, and P3U1 cells. Trypsin favors basic residues such as lysine
and arginine, while chymotrypsin favors aromatic residues such as
phenylalanine, tyrosine, and tryptophan [32]. On hepatoma tissue
culture (HTC) cells, almost all surface proteins are sensitive, to
some degree, to proteolysis by trypsin (with the exclusion of some
glycoproteins) [33]. To confirm surface protein disruption by the
proteases, the treated cells were incubated with a second protein
known to interact with protein on the untreated cells, and
attachment was completely ablated (unpublished data). This
suggests that the proteins on the cell surface were effectively
destroyed, while rP104-1-S/Fc adhesion to the host cells was
unaffected (Fig. 5A and B). Thus, rP104-1-S/Fc likely does not
adhere to cells through protein receptors that are sensitive to
digestion by trypsin or chymotrypsin. In a subsequent experiment,
a nitrocellulose membrane lipid strip spotted with 15 different
biologically abundant lipids found in cell membranes was
interacted with rP104-1-S/Fc or Fc. Interestingly, rP104-1-S/Fc
showed the same reaction as the negative control (Fc). Both
proteins reacted with phosphatidic acid (PA), phosphatidylinositol
(PtdIns)(3,4,5)P3, PtdIns(4,5)P2, and PtdIns(4) (Fig. 5C), which
suggests that rP014-1-S/Fc bound to the above lipids through the
Fc fragment but not P104-1-S portion. Therefore, none of the
examined 15 types of lipids functions as a receptor for P104-1-S.
The reason for the binding of Fc to lipids is unknown yet.
Attachment of rP104-1-S/Fc to CS
rP104-1-S/Fc was incubated with various glycans, including
glucose, lactose, CSA, and CSC, for 1 h at 4uC in a binding assay
with 293T, CHO-K1, or Vero cells. CSA and CSC significantly
inhibited the binding activity of rP104-1-S/Fc (data not shown).
Moreover, CSA and CSC inhibited the binding of rP104-1-S/Fc
to CHO-K1 cells in a dose-dependent manner. When the
concentration of CSA or CSC was greater than 1 mg/ml, CSA
showed slightly higher inhibitory activity toward rP104-1-S/Fc
than CSC (Fig. 6A). To corroborate this binding model, two
Figure 6. CS is necessary for the adhesion of rP104-1-S/Fc to cells. A. Inhibitory effect of CS on the binding activity of rP104-1-S/Fc to CHO-K1
cells. The inhibitory effect of CSA and CSC on the activity of rP104-1-S/Fc was calculated as the ratio of the geometric mean fluorescence intensity value
(GMean): (1-CSA-treated cells/no treated cells)6100. The experiment was performed in triplicate. B. Binding activity of rP104-1-S/Fc to CHO-K1 mutant
cells. The upper panel shows the ratio of the GMean as (rP104-1-S/Fc-mutant cells/rP104-1-S/Fc-wild cells-1) 6100; the experiment was performed in
triplicate. The lower panel shows the change in fluorescence as evaluated by FACS assay. Different colors indicate the different types of cells and
treatments: CHO-K1 (black), Fc-treated CHO-K1 (light green), rP104-1-S/Fc-treated CHO-K1 (red filled histogram), pgsA-745 (dark blue), Fc-treated pgsA-
745 (purple), rP104-1-S/Fc-treated pgsA-745 (light blue), pgsD-677 (yellow), Fc-treated pgsD-677 (dark red), and rP104-1-S/Fc-treated pgsD-677 (dark
green). C. Binding of CSA-conjugated beads to rP104-1-S/Fc. CSA-conjugated beads were incubated with rP104-1-S/Fc and then stained with HRP-
conjugated anti-mouse antibodies. The bands indicate that rP104-1-S/Fc was co-purified with the CSA-coupled beads. Lane 1, input rP104-1-S/Fc; 2,
mock beads incubated with rP104-1-S/Fc; 3, CSA-treated beads incubated with rP104-1-S/Fc. The molecular masses in kDa are shown on the left.
doi:10.1371/journal.pone.0030169.g006
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the binding assay, and our results demonstrate that pgsA-745
decreased the binding trend while pgsD-677 increased this trend by
54% when the binding activity of rP104-1-S/Fc to wild type of
CHO-K1 was considered as zero (Fig. 6B). Furthermore, CSA was
coupled to CNBr-activated beads and incubated with rP104-1-S/
Fc. rP104-1-S/Fc was co-purified with the CSA-conjugated beads,
but not with control beads (Fig. 6C).
In vitro inhibitory effect of rP104-1-S/Fc on T. gondii
invasion
To evaluate the significance of rP104-1-S/Fc as a vaccine
candidate, we added rP104-1-S/Fc to Vero cells to block its
receptors, and then investigated the invasion rate of T. gondii. With
the invasion rate of the control group (no protein added) set at
100%, treatment with Fc and rP104-1-S/Fc decreased the
infection rate. Compared with the Fc-treated group, rP104-1-S/
Fc significantly affected the infection rate of the parasite on the
concentrations of both 0.6 mM (67.75610.06 versus 42.97615.37,
student’ s t test, P,0.05) and 1.5 mM (75.28620.59 versus
48.6069.86, student’ s t test, P,0.05) (Fig. 7A). As a receptor
for rP104-1-S/Fc, exogenous CSA may compete with CSA on the
cell surface for adherence to T. gondii, thus impeding invasion of
the parasite. As expected, the addition of CSA inhibited the
invasion of T. gondii in a dose-dependent manner (Fig. 7B).
Discussion
The apple domain is a subset of PAN superfamily, which is
widely detected in various organisms, including bacteria [34],
apicomplexcans [13,35–39], filamentous fungi [40], plants [41],
nematodes [17], amphibians [42], avians [43], and mammals
[44]. These molecules all contain a PAN/apple domain that
mediates protein-protein or protein-carbohydrate interactions. As
mentioned, TgAMA1 [14] and TgMIC4 [13] contain 2 and 6
PAN/apple domains, respectively, which play an important role
in the invasion process [16,45]. This study identified a third
PAN/apple domain-containing protein, P104, which contains 10
putative PAN/apple domains. This large number of PAN/apple
domains may function as well as those found in Eimeria tenella
MIC5 (EtMIC5) [35], which facilitates the molecules to project
away from the parasite surface [46]. This is consistent with the
role of EtMIC5 in host cell binding [47]. Double staining of
extracellular T. gondii revealed an unexpected result that P104
was not co-localized with proteins from the microneme, rhoptry
or dense granules, but appeared on the apical end and possible
conoid of the parasite (Fig. 3B). It is a coincidence that
Morrissette et al. have previously detected a protein of 104 kDa
at the apical part of T. gondii, with exclusion of microneme,
rhoptry or dense granules, using monoclonal antibodies which
specifically recognize the extreme apex of the parasite [48].
Although the intracellular expression of P104 (as a recombinant
protein with FLAG tag) in PV, as observed to co-localize with
GRA6, is not consistent with the one that Morrissette et al. have
described, which may be attributed to the effect of the GRA1
promoter that possibly misguided the secretion of the recombi-
nant protein in transfected parasite, it is intriguing to determine
whether P104 in this study is the same one as mentioned by
Morrissette et al. Since we did not specifically detect the
expression of P104 in intracellular parasite using mouse anti-
rP104-1-S/GST antibody, other experiment is necessary for the
confirmation of the expression model of P104.
In this study, rP104-1-S/Fc bound various types of mammalian
and two types of insect cells, which may hint that T. gondii has
evolved some proteins to adhere the ubiquitously expressing
molecules thus extended its host range [49]. The recombinant
protein of A9 and A10 domains in P104 (rP104-2/Fc) showed low
binding activity to K562 cells (Fig. 4C). This attachment may be
mediated by an interaction of the Fc fragment on the fusion
protein with the 40-kDa Fc receptor (Fc gamma RII) on K562
cells [50], though the function of A9 and A10 remains unknown.
Previous work suggests that T. gondii uses sulfated proteoglycans
as substrates for host cell attachment. Exogenous CSA and CSC
significantly affected the gliding motility and disrupted the
adhesion of T. gondii to human fibroblasts at high concentrations
[18]. Removal of chondroitin sulphate A, B and C on cell surface
decreased Neospora caninum binding to Vero cells [51]. CS is also
necessary for invasion of the mosquito midgut by Plasmodium
ookinetes [52], which suggests an important role for CSA in the
invasion of apicomplexans. In N. caninum, NcMIC4 [36] and
NcMIC3 [51] were proved ligands for chondroitin sulphate
binding. In Plasmodium, Duffy binding-like domains possess CSA
binding activity and can protect against pregnancy-associated
Figure 7. In vitro inhibitory effect of rP104-1-S/Fc or CSA on the
invasion of T. gondii. Monolayers of Vero cells in an 8-well chamber
s l i d ew e r ei n f e c t e dw i t h2 610
5 GFP-expressing T. gondii after
incubation with different concentrations of rP104-1-S/Fc (A) or CSA
(B). Extracellular and intracellular parasites were stained differentially
and enumerated as described in method section. The invasion rate was
calculated as the ratio of parasites/cells in the tested group compared
to that in the mock group (Vero cells treated with no protein prior to
infection with T. gondii). Fc was used as a negative control. Student’s t-
test, asterisk, P,0.05; mean 6 standard deviation (n=3 experiments).
doi:10.1371/journal.pone.0030169.g007
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unknown. This study revealed the protein employed by T. gondii to
attach to CS on host cells. Cells defective in CS showed reduced
binding activity to rP104-1-S/Fc, and rP104-1-S/Fc was co-
purified with CSA-coupled beads (Fig. 6). This confirmed the
interaction of rP104-1-S with CS. However, CSA and CSC did
not completely inhibit the binding of rP104-1-S/Fc to host cells in
our study. Even mutant cells depleted of GAGs were not entirely
resistant to rP104-1-S/Fc binding, suggesting that other molecules
are also involved in the interaction. This hypothesis requires
further investigation.
In this study, the addition of rP104-1-S/Fc significantly
decreased the invasion rate of T. gondii, which suggests that
exogenous rP104-1-S/Fc competitively adheres to CSA, CSC, or
some other molecule, and partially affects host cell attachment and
invasion by the parasite. Though the protection of rP104-1-S/Fc
was not as prominent as that of SAG1, GRA1, GRA4 or GRA7
[54], it may be developed to co-operate with other proteins to
vaccinate against Toxoplasma. CSA seriously impacted the
infectivity of the parasite, consistent with previous results [18].
The results indicate that the control protein Fc decreased invasion
by T. gondii. This may be explained by Fc receptor activity on the
T. gondii tachyzoite. In this study, the Fc fragment was derived
from mouse IgG2a. A decade ago, mouse monoclonal IgG2a
antibodies were shown to bind the T. gondii membrane, and it was
found that the binding site was not the Fab domain but the Fc
fragment [55].
PAN/apple domain proteins in T. gondii may perform different,
but important, functions separately or collaboratively. Therefore,
our work is crucial for understanding the molecules that are
involved in the invasion process, and could lead to the
development of drugs or vaccine candidates for T. gondii.
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